Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Product Stability01:16

Drug Product Stability

223
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
223
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

199
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
199

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

bioRxiv : the preprint server for biology·2026
Same author

Retail cattle meat as a reservoir of multidrug-resistant Salmonella harboring β-lactamase genes in Sylhet, Bangladesh.

Veterinary research communications·2026
Same author

Impact of Low-Dose Cranberry Polyphenols on Gut Microbiota and Circulating Polyphenol Metabolites in Overweight and Obese Individuals (A Randomized Double-Blind Placebo-Controlled Clinical Pilot Study).

Food science & nutrition·2026
Same author

Antibiofilm Mechanisms and Applications of Natural Compounds.

Journal of food protection·2026
Same author

A Multidisciplinary Review of the Microbial, Functional, and Consumer Advancement of Indian Lassi.

Probiotics and antimicrobial proteins·2026
Same author

Fertile field emission response in scrambled SmNiO<sub>3</sub> nanopins.

Scientific reports·2026

相关实验视频

Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K

益生菌开发战略以稳定性和监管考虑为中心.

Hye Kim1, Ariful Haque1, Abdur Razzak1

  • 1Department of Food Science and Technology, Texas A&M University, College Station, Texas, USA.

Comprehensive reviews in food science and food safety
|January 6, 2026
PubMed
概括

开发有效的益生菌需要将实验室发现与工业需求相结合. 标准化评估和监管协调是下一代益生菌安全高效商业化的关键.

科学领域:

  • 微生物学和生物技术
  • 食品科学与技术 食品科学与技术
  • 监管科学 监管科学

背景情况:

  • 益生菌菌株的开发在将实验室疗效转化为工业规模稳定性和性能方面面临挑战.
  • 消费者需求和健康益处推动了益生菌的重要学术和工业研究.
  • 在已证明的功能成果与商业化要求之间存在差距,阻碍了市场进入.

研究的目的:

  • 批判性地审查益生菌开发管道,从菌株查到监管框架.
  • 检查生产压力因素对益生菌菌株生存能力的影响以及提高弹性策略的有效性.
  • 将全球监管体系进行比较,并强调需要统一的评估框架.

主要方法:

  • 关于益生菌菌株查和弹性策略的研究文献综述.
  • 对生产压力因素 (热量,氧气,消化) 对菌株生存能力的分析.
  • 美国,欧盟,日本,韩国和中国监管框架的比较分析.

主要成果:

  • 热冲击和微封装等适应性策略显示了菌株存活率的可变改善 (分别高达31倍和100倍),突出了菌株特异性和可重复性问题.
  • 生产压力因素显著影响益生菌的生存能力,需要有针对性的弹性战略.
  • 全球分类,安全和功能实证法规的异质性使得国际市场的准入更加复杂.
关键词:
微封装是一种微封装方式.益生菌是一种益生菌.监管框架 监管框架稳定的稳定性 稳定的稳定性菌株的发展和变种.

更多相关视频

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

相关实验视频

Last Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K
Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

结论:

  • 整合科学验证,工业性能和监管合规性的协调评估框架对于开发下一代益生菌至关重要.
  • 学术界,工业界和监管机构之间的持续合作对于益生菌有效性,安全性,可扩展性和经济可行性等方面的平衡进展至关重要.
  • 需要标准化的方法来克服益生菌的商业化差距.